欣吉健康 HNGE
$115.76 −$0.22 (-0.19%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $114.80 -0.83%
开盘$116.51
昨收$115.98
当日区间$111.00 – $118.70
成交量1.54M
市值$9.34B
市盈率（TTM）19.0
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$212.82M+53.0% YoY
营业利润$40.44M+107.0% YoY
净利润$43.69M+107.6% YoY
摊薄每股收益$0.52+104.0% YoY
自由现金流$99.56M+441.1% YoY
经营现金流$101.41M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率84.5%
营业利润率13.0%
净利率14.9%
净资产收益率41.4%
资产收益率14.1%
投入资本回报率40.2%
流动比率1.34
负债/资产比率58.4%
现金及投资$389.39M
总负债$1.63M
净现金（净负债）$387.76M
自由现金流/营收39.4%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $212.82M | $182.31M | $587.86M | $170.73M | $154.21M |
| 营业总收入 | $212.82M | $182.31M | $587.86M | $170.73M | $154.21M |
| 营业成本 | $28.87M | $28.07M | $119.64M | $26.70M | $28.01M |
| 毛利润 | $183.95M | $154.23M | $468.22M | $144.03M | $126.20M |
| 营业费用 | $143.51M | $122.16M | $1.01B | $116.77M | $132.29M |
| 销售及管理费用 | $109.45M | $91.83M | $646.46M | $84.02M | $100.37M |
| -销售及营销费用 | $81.41M | $68.80M | $316.95M | $59.49M | $63.52M |
| -管理费用 | $28.04M | $23.02M | $329.51M | $24.53M | $36.85M |
| 研发费用 | $34.06M | $30.34M | $368.14M | $32.76M | $31.92M |
| 营业利润 | $40.44M | $32.07M | -$546.37M | $27.26M | -$6.09M |
| 其他收入（支出） | $3.99M | $3.87M | $19.11M | $4.96M | $4.46M |
| 其他非经营性收入（支出） | $3.99M | $3.87M | $19.11M | $4.96M | $4.46M |
| 税前利润 | $44.43M | $35.94M | -$527.26M | $32.22M | -$1.64M |
| 税费 | $740,000.00 | $814,000.00 | $998,000.00 | $122,000.00 | $206,000.00 |
| 净利润 | $43.69M | $35.13M | -$528.26M | $32.10M | -$1.84M |
| 持续经营利润 | $43.69M | $35.13M | -$528.26M | $32.10M | -$1.84M |
| 归属母公司净利润 | $43.69M | $35.13M | -$528.26M | $32.10M | -$1.84M |
| 其他优先股股息 | $588,000.00 | $1.12M | -$104.17M | $0.00 | $0.00 |
| 归属普通股股东净利润 | $43.10M | $34.01M | -$424.09M | $32.10M | -$1.84M |
| 基本每股收益 | $0.55 | $0.43 | -$7.77 | $0.39 | -$0.02 |
| 摊薄每股收益 | $0.52 | $0.41 | -$7.77 | $0.37 | -$0.02 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $827.40M | $728.77M | $744.76M | $744.76M | $769.80M |
| 流动资产合计 | $643.35M | $540.05M | $533.90M | $533.90M | $658.88M |
| 现金及现金等价物与短期投资 | $389.39M | $315.87M | $363.86M | $363.86M | $480.03M |
| -现金及现金等价物 | $286.22M | $186.67M | $208.00M | $208.00M | $261.34M |
| -短期投资 | $103.17M | $129.20M | $155.87M | $155.87M | $218.69M |
| 应收款 | $125.43M | $114.92M | $66.06M | $66.06M | $86.77M |
| -应收账款 | $91.79M | $69.60M | $51.04M | $51.04M | $59.98M |
| -其他应收款 | $40.35M | $51.28M | $21.12M | $21.12M | $34.03M |
| -应收款调整准备 | -$6.71M | -$5.96M | -$6.09M | -$6.09M | -$7.25M |
| 预付资产 | $35.38M | $31.34M | $30.93M | $30.93M | $24.98M |
| 存货 | $16.77M | $14.17M | $15.64M | $15.64M | $13.81M |
| 一年内递延资产 | $68.54M | $56.36M | $50.94M | $50.94M | $48.91M |
| 其他流动资产 | $7.84M | $7.40M | $6.47M | $6.47M | $4.38M |
| 非流动资产合计 | $184.05M | $188.72M | $210.86M | $210.86M | $110.92M |
| 固定资产净值 | $17.77M | $17.31M | $17.35M | $17.35M | $16.14M |
| -固定资产原值 | $37.77M | $37.68M | $37.13M | $37.13M | $35.94M |
| -累计折旧 | -$20.00M | -$20.37M | -$19.78M | -$19.78M | -$19.80M |
| 投资及预付款 | $84.74M | $89.77M | $113.17M | $113.17M | $15.08M |
| -可供出售证券 | $84.74M | $89.77M | $113.17M | $113.17M | $15.08M |
| 商誉及其他无形资产 | $66.16M | $66.38M | $66.61M | $66.61M | $66.83M |
| -商誉 | $64.10M | $64.10M | $64.10M | $64.10M | $64.10M |
| -其他无形资产 | $2.06M | $2.29M | $2.51M | $2.51M | $2.74M |
| 其他非流动资产 | $15.37M | $15.26M | $13.73M | $13.73M | $12.87M |
| 负债合计 | $483.07M | $417.21M | $366.23M | $366.23M | $361.93M |
| 流动负债合计 | $481.44M | $414.48M | $362.41M | $362.41M | $357.08M |
| 应付款 | $9.08M | $8.82M | $6.17M | $6.17M | $2.76M |
| -应付税款合计 | $9.08M | $8.82M | $6.17M | $6.17M | $2.76M |
| 一年内应计费用 | $42.46M | $47.40M | $39.70M | $39.70M | $35.31M |
| 短期债务及融资租赁负债 | $4.25M | $4.23M | $4.22M | $4.22M | $4.18M |
| -一年内到期融资租赁负债 | $4.25M | $4.23M | $4.22M | $4.22M | $4.18M |
| 一年内递延负债 | $416.47M | $340.77M | $300.86M | $300.86M | $299.70M |
| 非流动负债合计 | $1.63M | $2.74M | $3.82M | $3.82M | $4.85M |
| 长期债务及融资租赁负债 | $1.63M | $2.74M | $3.82M | $3.82M | $4.85M |
| -长期融资租赁负债 | $1.63M | $2.74M | $3.82M | $3.82M | $4.85M |
| 股东权益合计 | $344.33M | $311.56M | $378.54M | $378.54M | $407.87M |
| 股东权益 | $344.33M | $311.56M | $378.54M | $378.54M | $407.87M |
| 股本 | $0.00 | $199.87M | $199.87M | $199.87M | $199.87M |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -优先股 | $0.00 | $199.87M | $199.87M | $199.87M | $199.87M |
| 资本公积 | $1.32B | $1.13B | $1.23B | $1.23B | $1.29B |
| 留存收益 | -$972.18M | -$1.02B | -$1.05B | -$1.05B | -$1.08B |
| 不影响留存收益的损益 | -$364,000.00 | -$348,000.00 | -$20,000.00 | -$20,000.00 | $53,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $101.41M | $43.08M | $171.44M | $63.89M | $82.40M |
| 持续经营经营活动现金流净额 | $101.41M | $43.08M | $171.44M | $63.89M | $82.40M |
| 持续经营净利润 | $43.69M | $35.13M | -$528.26M | $32.10M | -$1.84M |
| 折旧、折耗与摊销 | $1.06M | $1.17M | $5.13M | $1.22M | $1.26M |
| 递延税款 | $13,000.00 | $0.00 | $53,000.00 | -$93,000.00 | $50,000.00 |
| 其他非现金项目 | $20.01M | $17.11M | $50.10M | $15.11M | $13.43M |
| 营运资金变动 | $15.36M | -$22.16M | -$2.01M | -$1.32M | $34.04M |
| -应收款变动 | -$12.12M | -$48.86M | -$26.63M | $20.98M | $11.97M |
| -存货变动 | -$2.60M | $1.47M | -$4.76M | -$1.82M | $175,000.00 |
| -预付资产变动 | -$7.73M | -$3.59M | -$15.78M | -$7.77M | -$1.39M |
| -应付账款及应计费用变动 | -$8.65M | $11.25M | $29.41M | $4.42M | $17.99M |
| -其他流动资产变动 | $331,000.00 | -$658,000.00 | -$181,000.00 | $7.97M | -$7.66M |
| -其他流动负债变动 | -$1.08M | -$1.07M | -$3.72M | -$995,000.00 | -$932,000.00 |
| -其他营运资金变动 | $47.23M | $19.31M | $19.64M | -$24.10M | $13.89M |
| 投资活动现金流净额 | $28.62M | $48.08M | -$113.76M | -$37.70M | -$58.76M |
| 持续经营投资活动现金流净额 | $28.62M | $48.08M | -$113.76M | -$37.70M | -$58.76M |
| 资本支出 | -$1.73M | -$1.45M | -$5.36M | -$1.96M | -$1.07M |
| 固定资产购置及出售净额 | -$123,000.00 | -$83,000.00 | -$708,000.00 | -$408,000.00 | -$52,000.00 |
| 业务购买及出售净额 | $0.00 | $0.00 | -$4.00M | $0.00 | $0.00 |
| 投资购置及出售净额 | $30.47M | $49.61M | -$103.70M | -$35.33M | -$57.64M |
| 筹资活动现金流 | -$30.48M | -$112.85M | -$150.47M | -$79.55M | $531,000.00 |
| 持续经营筹资活动现金流净额 | -$30.48M | -$112.85M | -$150.47M | -$79.55M | $531,000.00 |
| 债务发行及偿还净额 | $0.00 | $0.00 | $4.93M | $0.00 | $0.00 |
| 普通股发行净额 | -$26.53M | -$104.97M | $190.65M | -$65.03M | $0.00 |
| 股票期权行使所得 | $7.55M | $410,000.00 | $9.53M | $8.74M | $531,000.00 |
| 其他筹资费用净额 | -$11.50M | -$8.29M | -$355.58M | -$23.26M | $0.00 |
| 期末现金余额 | $287.67M | $188.11M | $209.80M | $209.80M | $263.14M |
| 现金净变动 | $99.55M | -$21.68M | -$92.79M | -$53.35M | $24.17M |
| 期初现金余额 | $188.11M | $209.80M | $302.59M | $263.14M | $238.97M |
| 自由现金流 | $99.56M | $41.55M | $165.38M | $61.53M | $81.28M |
暂无评论——快来第一个聊聊 HNGE。
登录后参与讨论。